Back to search

Poland· PL-100502472

Dasatinib Accord Healthcare

A dasatinib product containing dasatinibum, registered in Poland by Accord Healthcare S.L.U.. The same ATC class is registered in 14 of our 19 countries.

ATC L01EA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDasatinib Accord HealthcareATCL01EA02REGISTER NO.PL-100502472PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Dasatinib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EA02 (dasatinib), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Dasatinib · ATC L01EA02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dasatinib costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Dasatinib · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$48.85
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Dasatinibum
Manufacturer
Accord Healthcare S.L.U.
Country
Poland (PL)
ATC code
L01EA02
ATC class
Dasatinib
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05055565799215

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

797 interactions on record for dasatinib.

Graded by severity as the source publishes them — 245 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dasatinib · interactions on record

797 records

  • 245 severe
  • 479 moderate
  • 13 minor
  • 60 info

Most severe, free to view

  • CimetidineA02BA01severe
  • RanitidineA02BA02severe
  • FamotidineA02BA03severe
  • NizatidineA02BA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dasatinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dasatinib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Daruph, Dasatinib G.L.
  • Belgium · Dasatinib Krka, Dasatinib Sandoz
  • Bulgaria · Dasatinib Sandoz, Дазатиниб Зентива
  • Cyprus · Dasatinib Teva, Specenib
  • Czechia · Daruph, Dasatinib Msn
  • Germany · Daruph, Dasa-Abz
  • Denmark · Dasatinib "sandoz", Dasatinib Krka
  • Estonia · Dasatinib Teva, Dasatinib Viatris
  • Spain · Daruph, Dasatinib
  • Finland · Dasatinib Avansor, Dasatinib Krka
  • France · Dasatinib Arrow, Dasatinib Biogaran
  • United Kingdom (Northern Ireland) · Dasatinib Accord, Dasatinib Generics Uk
  • Greece · Dasatinib Faran, Dasatinib Teva
  • Croatia · Dasatinib Alpha-Medical, Dasatinib Stada
  • Hungary · Daruph, Dasatinib Krka
  • Ireland · Dasatinib Clonmel, Dasatinib Krka
  • Iceland · Dasatinib Accord Healthcare, Dasatinib Krka
  • Italy · Dasatinib Aurobindo, Dasatinib Eg
  • Liechtenstein · Dasatinib Accord, Dasatinib Accord Healthcare
  • Lithuania · Dasatinib Krka, Dasatinib Teva
  • Luxembourg · Dasatinib Teva, Dasatinib Viatris
  • Latvia · Dasatinib Teva, Dasatinib Viatris
  • Malta · Dasatinib Clonmel, Dasatinib Synthon
  • Netherlands · Dasatinib Cf, Dasatinib Krka
  • Norway · Dasatinib Accord Healthcare, Dasatinib Krka
  • Portugal · Dasatinib Eugia, Dasatinib Generis
  • Romania · Dasatinib Krka, Dasatinib Msn
  • Sweden · Daruph, Dasatinib
  • Slovenia · Dasatinib Krka, Dasatinib Sandoz
  • Slovakia · Daruph, Dasatinib Krka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc480253-de38-40df-991a-9e487305c2da
GET /v1/drugs/fc480253-de38-40df-991a-9e487305c2da?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "Rpz ¦ EU/1/24/1839/001 ¦ 157526\n56 tabl.\n05055565799215 ¦ Rpz ¦ EU/1/24/1839/002 ¦ 157527\n60 tabl.\nRpz ¦ EU/1/24/1839/004 ¦ 157528\n60 tabl. w blistrach perforowanych\nRpz ¦ EU/1/24/1839/003 ¦ 157529\n56 tabl. w blistrach perforowanych",
  "substance": "Dasatinibum 20 mg",
  "common_name": "Dasatinibum",
  "pl_product_id": "100502472",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about dasatinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.